The combination treatment resulted in a similar frequency of disease stabilisation and overall showed a trend toward lower fold change values, suggesting improved tumour control ( Figure 4B ).
← all excerpts
Wnt3a-expressing cancer stem cells impair CD8<sup>+</sup> TRM function, contributing to immunotherapy resistance in Melanoma.
1
—
—